Libánská A - Search Results

1

Definitive proof of graphene hydrogenation by Clemmensen reduction: use of deuterium labeling.

Sofer Z, Jankovský O, Libánská A, Šimek P, Nováček M, Sedmidubský D, Macková A, Mikšová R, Pumera M. Sofer Z, et al. Among authors: libanska a. Nanoscale. 2015 Jun 21;7(23):10535-43. doi: 10.1039/c5nr01356a. Nanoscale. 2015. PMID: 26015058

2

Partially Hydrogenated Graphene Materials Exhibit High Electrocatalytic Activities Related to Unintentional Doping with Metallic Impurities.

Jankovský O, Libánská A, Bouša D, Sedmidubský D, Matějková S, Sofer Z. Jankovský O, et al. Among authors: libanska a. Chemistry. 2016 Jun 13;22(25):8627-34. doi: 10.1002/chem.201600811. Epub 2016 May 11. Chemistry. 2016. PMID: 27167069

3

Fluorographene Modified by Grignard Reagents: A Broad Range of Functional Nanomaterials.

Mazánek V, Libánská A, Šturala J, Bouša D, Sedmidubský D, Pumera M, Janoušek Z, Plutnar J, Sofer Z. Mazánek V, et al. Among authors: libanska a. Chemistry. 2017 Feb 3;23(8):1956-1964. doi: 10.1002/chem.201604989. Epub 2017 Jan 10. Chemistry. 2017. PMID: 27882624

4

Using surface plasmon resonance, capillary electrophoresis and diffusion-ordered NMR spectroscopy to study drug release kinetics.

Libánská A, Špringer T, Peštová L, Kotalík K, Konefał R, Šimonová A, Křížek T, Homola J, Randárová E, Etrych T. Libánská A, et al. Commun Chem. 2023 Aug 31;6(1):180. doi: 10.1038/s42004-023-00992-5. Commun Chem. 2023. PMID: 37653020 Free PMC article.

5

HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours.

Kostka L, Kotrchová L, Šubr V, Libánská A, Ferreira CA, Malátová I, Lee HJ, Barnhart TE, Engle JW, Cai W, Šírová M, Etrych T. Kostka L, et al. Among authors: libanska a. Biomaterials. 2020 Mar;235:119728. doi: 10.1016/j.biomaterials.2019.119728. Epub 2019 Dec 26. Biomaterials. 2020. PMID: 32044514 Free PMC article.

6

Dexamethasone nanomedicines with optimized drug release kinetics tailored for treatment of site-specific rheumatic musculoskeletal diseases.

Libánská A, Randárová E, Rubanová D, Skoroplyas S, Bryja J, Kubala L, Konefal R, Navrátilová A, Cerezo LA, Šenolt L, Etrych T. Libánská A, et al. Int J Pharm. 2024 Apr 10;654:123979. doi: 10.1016/j.ijpharm.2024.123979. Epub 2024 Mar 7. Int J Pharm. 2024. PMID: 38458405

7

Polymer Nanomedicines with Ph-Sensitive Release of Dexamethasone for the Localized Treatment of Inflammation.

Libánská A, Randárová E, Lager F, Renault G, Scherman D, Etrych T. Libánská A, et al. Pharmaceutics. 2020 Jul 25;12(8):700. doi: 10.3390/pharmaceutics12080700. Pharmaceutics. 2020. PMID: 32722403 Free PMC article.

8

Therapeutic activity and biodistribution of a nano-sized polymer-dexamethasone conjugate intended for the targeted treatment of rheumatoid arthritis.

Rubanová D, Skoroplyas S, Libánská A, Randárová E, Bryja J, Chorvátová M, Etrych T, Kubala L. Rubanová D, et al. Among authors: libanska a. Nanomedicine. 2024 Jan;55:102716. doi: 10.1016/j.nano.2023.102716. Epub 2023 Oct 30. Nanomedicine. 2024. PMID: 38738529

9

Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis.

Libánská A, Randárová E, Skoroplyas S, Bartoš M, Luňáčková J, Lager F, Renault G, Scherman D, Etrych T. Libánská A, et al. J Control Release. 2023 Jan;353:30-41. doi: 10.1016/j.jconrel.2022.11.027. Epub 2022 Nov 21. J Control Release. 2023. PMID: 36403682

10

Combination effect with some aminoglycoside antibiotics.

Jedlicková Z, Rýc M, Libánská A. Jedlicková Z, et al. Among authors: libanska a. J Hyg Epidemiol Microbiol Immunol. 1981;25(2):204-6. J Hyg Epidemiol Microbiol Immunol. 1981. PMID: 6788839

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters